149 related articles for article (PubMed ID: 12445683)
21. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
22. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein.
Flück M; Zürcher G; Andres AC; Ziemiecki A
Biochem Biophys Res Commun; 1995 Aug; 213(1):273-81. PubMed ID: 7639745
[TBL] [Abstract][Full Text] [Related]
24. Full-length spleen tyrosine kinase inhibits the invasion and metastasis of human laryngeal squamous cell carcinoma.
Li Z; Cai Z; Tao B; Jin Q
Int J Clin Exp Pathol; 2015; 8(12):15786-93. PubMed ID: 26884848
[TBL] [Abstract][Full Text] [Related]
25. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.
Kurosaki T; Takata M; Yamanashi Y; Inazu T; Taniguchi T; Yamamoto T; Yamamura H
J Exp Med; 1994 May; 179(5):1725-9. PubMed ID: 7513017
[TBL] [Abstract][Full Text] [Related]
26. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
[TBL] [Abstract][Full Text] [Related]
27. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer.
Dai JL; Wang L; Sahin AA; Broemeling LD; Schutte M; Pan Y
Oncogene; 2004 Nov; 23(53):8681-7. PubMed ID: 15467753
[TBL] [Abstract][Full Text] [Related]
28. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression.
Coopman PJ; Mueller SC
Cancer Lett; 2006 Sep; 241(2):159-73. PubMed ID: 16442709
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of elevated spleen tyrosine kinase expression in nasopharyngeal carcinoma.
Du ZM; Kou CW; Wang HY; Huang MY; Liao DZ; Hu CF; Chen J; Yan LX; Hu LF; Ernberg I; Zeng YX; Shao JY
Head Neck; 2012 Oct; 34(10):1456-64. PubMed ID: 22287277
[TBL] [Abstract][Full Text] [Related]
30. FcgammaRIIA exogenously expressed in HeLa cells activates the mitogen-activated protein kinase cascade by a mechanism dependent on the endogenous expression of the protein tyrosine kinase Syk.
Renedo MA; Fernández N; Crespo MS
Eur J Immunol; 2001 May; 31(5):1361-9. PubMed ID: 11465093
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel SNPs in SYK gene of breast cancer patients: computational analysis of SNPs in the 5'UTR.
Kanwal S; Kayani MA; Faryal R
Mol Biol Rep; 2012 Aug; 39(8):8345-51. PubMed ID: 22707146
[TBL] [Abstract][Full Text] [Related]
32. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
[TBL] [Abstract][Full Text] [Related]
33. Structure and function of Syk protein-tyrosine kinase.
Sada K; Takano T; Yanagi S; Yamamura H
J Biochem; 2001 Aug; 130(2):177-86. PubMed ID: 11481033
[TBL] [Abstract][Full Text] [Related]
34. Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells.
Tsujimura T; Yanagi S; Inatome R; Takano T; Ishihara I; Mitsui N; Takahashi S; Yamamura H
FEBS Lett; 2001 Feb; 489(2-3):129-33. PubMed ID: 11165236
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling.
Chan AC; van Oers NS; Tran A; Turka L; Law CL; Ryan JC; Clark EA; Weiss A
J Immunol; 1994 May; 152(10):4758-66. PubMed ID: 8176201
[TBL] [Abstract][Full Text] [Related]
36. [Biological mechanism of full-length form of spleen tyrosine kinase regulating gene transcription in breast cancer cells].
Wang L; Hu Y; Yang ZL; Song XM; Wang JP
Ai Zheng; 2007 May; 26(5):469-72. PubMed ID: 17672934
[TBL] [Abstract][Full Text] [Related]
37. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
38. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
[TBL] [Abstract][Full Text] [Related]
39. Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production.
Yamada T; Fujieda S; Yanagi S; Yamamura H; Inatome R; Sunaga H; Saito H
J Immunol; 2001 Jan; 166(1):538-43. PubMed ID: 11123334
[TBL] [Abstract][Full Text] [Related]
40. Cloning of the cDNA for the deleted syk kinase homologous to ZAP-70 from human basophilic leukemia cell line (KU812).
Yagi S; Suzuki K; Hasegawa A; Okumura K; Ra C
Biochem Biophys Res Commun; 1994 Apr; 200(1):28-34. PubMed ID: 7513161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
